HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gopinathan Pillai Sreekanth Selected Research

FR 180204

8/2014Role of ERK1/2 signaling in dengue virus-induced liver injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gopinathan Pillai Sreekanth Research Topics

Disease

7Infections
02/2020 - 08/2014
3Thrombocytopenia (Thrombopenia)
01/2017 - 08/2014
1Edema (Dropsy)
10/2021
1Inflammation (Inflammations)
10/2021
1Hemorrhage
01/2019
1Wounds and Injuries (Trauma)
01/2019
1Virus Diseases (Viral Diseases)
08/2018
1Severe Dengue
08/2018

Drug/Important Bio-Agent (IBA)

3Transaminases (Aminotransferases)IBA
01/2017 - 08/2014
2Pharmaceutical PreparationsIBA
01/2019 - 01/2016
2Antiviral Agents (Antivirals)IBA
01/2019 - 01/2016
2CytokinesIBA
08/2018 - 01/2016
1DiarylheptanoidsIBA
10/2021
1Irritants (Vesicants)IBA
10/2021
1(3S)- 7- (3,4- dihydroxyphenyl)- 1- phenyl- (1E)- 1- hepten- 3- olIBA
10/2021
1Sunitinib (Sutent)FDA Link
02/2020
1trans-sodium crocetinate (crocetin)IBA
01/2020
1NF-kappa B (NF-kB)IBA
01/2020
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2019
1Anti-Bacterial Agents (Antibiotics)IBA
01/2019
1Cysteine (L-Cysteine)FDA Link
01/2019
1Mupirocin (Bactroban)FDA LinkGeneric
01/2019
1Mitogen-Activated Protein KinasesIBA
08/2018
1Interleukin-6 (Interleukin 6)IBA
01/2016
1Minocycline (Cyclops)FDA LinkGeneric
01/2016
1ChemokinesIBA
01/2016
1Chemokine CCL5IBA
01/2016
1p38 Mitogen-Activated Protein KinasesIBA
01/2016
1Interleukin-10 (Interleukin 10)IBA
01/2016
1SB 203580IBA
01/2016
1MAP-kinase-activated kinase 2IBA
01/2016
1Caspase 3 (Caspase-3)IBA
08/2014
1FR 180204IBA
08/2014

Therapy/Procedure

1Therapeutics
08/2018